SAFETY AND EFFICACY OF INTRATHECAL ANTIBODIES TO NOGO-A IN PATIENTS WITH ACUTE CERVICAL SPINAL CORD INJURY: A RANDOMISED, DOUBLE-BLIND, MULTICENTRE, PLACEBO-CONTROLLED, PHASE 2B TRIAL.

Weidner N, Abel R, Maier D, Röhl K, Röhrich F, Baumberger M, Hund-Georgiadis M, Saur M, Benito J, Rehahn K, Aach M, Badke A, Kriz J, Barkovits K, Killeen T, Farner L, Seif M, Hubli M, Marcus K, Maurer MA, Robert B, Rupp R, Scheuren PS, Schubert M, Schuld C, Sina C, Steiner B, Weis T, Hug A, Bolliger M, Weiskopf N, Freund P, Hothorn T, Schwab ME, Curt A; Nogo Inhibition in Spinal Cord Injury Study Group.